Silverarc Capital Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Silverarc Capital Management’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-37,000	Closed	-$742K	–	88
2021 Q3	$742K	Sell	37,000 -89,145	-71%	-$2.3M	0.42%	60
2021 Q2	$3.89K	Sell	126,145 -8,410	-6%	-$252K	1.74%	17
2021 Q1	$3.45M	Sell	134,555 -6,698	-5%	-$168K	1.88%	18
2020 Q4	$2.26M	Buy	+141,253	New	+$1.74M	1.31%	29

Other funds holding RNLX

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

PCM

Philosophy Capital Management Alamo, California $1.63B AUM 12.69% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Silverarc Capital Management's RNLX Position: Q4 2021 in Review

Silverarc Capital Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2021, closing a stake of 37,000 shares — an estimated $742K sold.

Silverarc Capital Management first reported a position in RNLX in Q4 2020 and held it in 4 quarters. The position peaked at $3.45M in Q1 2021. 33 funds tracked by Wall St. Rank hold RNLX as of Q4 2021.

Silverarc Capital Management reported no remaining Renalytix plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Silverarc Capital Management sold 37,000 Renalytix plc American Depositary Shares shares in Q4 2021, an estimated $742K.
Silverarc Capital Management first reported a position in Renalytix plc American Depositary Shares in Q4 2020 and held it in 4 quarters.
Silverarc Capital Management's Renalytix plc American Depositary Shares position peaked at $3.45M in Q1 2021.
33 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2021.

Based on Silverarc Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.